Defining the mechanism of action of 4-phenylbutyrate to develop a small-molecule-based therapy for Alzheimer's disease.

by Cuadrado-Tejedor, M. (Mar), Garcia-Osta, A. (Ana), Ricobaraza, A. (Ana), Oyarzabal, J. (Julen), Franco, R. (Rafael)
Published 2012

Past, present and future of A(2A) adenosine receptor antagonists in the therapy of Parkinson's disease.ents. Correlates with Alzheimer disease

by Armentero, M.T. (Marie Therese), Pinna, A. (Annalisa), Ferre, S. (Sergi), Lanciego, J.L. (José Luis), Müller, C.E. (Christa E.), Franco, R. (Rafael)
Published 2012

Chronic mild stress accelerates the onset and progression of the Alzheimer's disease phenotype in tg2576 mice

by Cuadrado-Tejedor, M. (Mar), Ricobaraza, A. (Ana), Frechilla, D. (Diana), Franco, R. (Rafael), Perez-Mediavilla, L.A. (Luis Alberto), Garcia-Osta, A. (Ana)
Published 2012

Sildenafil restores cognitive function without affecting β-amyloid burden in a mouse model of Alzheimer's disease

by Garcia-Osta, A. (Ana), Aguirre, N. (Norberto), Franco, R. (Rafael), Garcia-Barroso, C. (C.), Perez-Roldan, J.M. (J.M.), Puerta, E. (Elena), Ricobaraza, A. (Ana), Hervias, I. (Isabel), Cuadrado-Tejedor, M. (Mar)
Published 2012